A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be ...

NEW YORK ― Transcranial magnetic stimulation (TMS) is a cost-effective treatment option for patients with resistant major depressive disorder (MDD), according to a new economic analysis. "It's mainly ...

Transcranial magnetic stimulation (TMS, or "rTMS" for "repetitive TMS") received an indication for treating major depressive disorder in 2008. Since then, research and clinical experience with TMS has ...

Repetitive transcranial magnetic stimulation (rTMS) and other targeted, noninvasive neuromodulation approaches offer promise for treating neuropsychiatric conditions. These techniques work by ...

BURLINGTON, Mass. and JERUSALEM, Oct. 16, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...

BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain ...

Moment of Clarity has published a new educational resource titled “Acccelerated TMS Therapy for Depression“, providing an in-depth look at how transcranial magnetic stimulation (TMS) technology is ...

At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant ...

Can magnetism move the needle in persistent depression — when the debilitating mental illness does not respond to different ...